LP profile · Other
Memorial Sloan Kettering
Memorial Sloan Kettering is a other headquartered in United States (North America). Ranked #103 in the 2026 Dealroom Power Law LP Ranking by realised power-law score across its venture commitments.
Historical Background
- Memorial Sloan Kettering (MSK) was founded in 1884 as the New York Cancer Hospital, the first institution in the United States dedicated exclusively to cancer treatment.
- The modern entity was formed in 1980 through the merger of Memorial Hospital and the Sloan-Kettering Institute, which had been established in 1945 through a gift from Alfred P. Sloan and Charles F. Kettering.
Source of Capital
- As a non-profit institution, MSK's capital is derived from a combination of patient care revenue, research grants, philanthropic donations, and returns from its investment portfolio.
- The investment office manages a substantial endowment to fund its research, clinical care, and educational missions.
Major Events
- In 1980, Memorial Hospital for the Treatment of Cancer and Allied Diseases formally merged with the Sloan-Kettering Institute for Cancer Research to create the unified Memorial Sloan Kettering Cancer Center.
- In 2020, MSK opened the David H. Koch Center for Cancer Care, a 750,000-square-foot outpatient facility in Manhattan.
Allocation Strategy
- No information available.
Sources
- https://www.mskcc.org/about/history-milestones
- https://www.mskcc.org/about/history-milestones/historical-timeline
- https://www.company-histories.com/Memorial-SloanKettering-Cancer-Center-Company-History.html
- https://www.zippia.com/memorial-sloan-kettering-cancer-center-careers-31030/history/
- https://www.ai-cio.com/news/how-memorial-sloan-kettering-funds-its-cancer-fight/
- https://www.fitchratings.com/research/us-public-finance/fitch-affirms-memorial-sloan-kettering-cancer-center-ny-rev-bonds-at-aa-outlook-stable-14-11-2024